Management of Cannabinoid Hyperemesis Syndrome (CHS)
The definitive management of cannabinoid hyperemesis syndrome requires complete cannabis cessation for at least 3-6 months, along with supportive care including IV fluid rehydration, dopamine receptor antagonists (particularly haloperidol), and topical capsaicin application. 1
Diagnosis
CHS should be suspected in patients presenting with:
- Stereotypical episodic vomiting (≥3 episodes annually)
- Cannabis use for >1 year before symptom onset
- Cannabis use frequency >4 times per week
- Relief from hot showers/baths (reported in 71% of cases)
- Resolution of symptoms after cannabis cessation 2, 1
Acute Management
First-line interventions:
- IV fluid rehydration to correct dehydration and electrolyte abnormalities
- Dopamine receptor antagonists:
- Haloperidol 0.5-2 mg IV or PO every 4-6 hours 1
- Topical capsaicin cream (0.1%) applied to abdomen with monitoring for efficacy and adverse effects 2, 1
- Encourage hot showers/baths which provide temporary symptom relief 1
Second-line options:
- Benzodiazepines: Lorazepam 0.5-2 mg PO/SL/IV every 6 hours 1, 3
- Olanzapine: 5-10 mg PO daily 1
- Promethazine for nausea control 4
- Ondansetron may provide some benefit 2
Important cautions:
- Avoid opioids due to risk of worsening nausea and high addiction potential 2
- Provide a quiet, supportive environment with minimal stimulation 1
- Ensure adequate hydration throughout treatment 1
Long-term Management
- Cannabis cessation counseling - the only definitive treatment 2, 1, 3
- Tricyclic antidepressants (e.g., amitriptyline):
- Patient education about the direct relationship between cannabis use and symptoms
- Regular follow-up to monitor for symptom recurrence and cannabis use
Clinical Pearls
- CHS is frequently misdiagnosed, leading to unnecessary testing and treatments 4
- The paradoxical relief with hot water bathing/showering is a distinctive feature that helps differentiate CHS from other causes of cyclic vomiting 6
- Symptoms typically resolve completely within 7-10 days of cannabis cessation 1
- Capsaicin may reduce the need for additional medications and decrease opioid requirements 7
- Emergency department differential diagnosis should include life-threatening conditions such as acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction 2
Treatment Challenges
- Many standard antiemetics show limited efficacy in CHS 5
- Patient resistance to accepting cannabis as the cause of symptoms is common
- High recurrence rate if cannabis use is resumed
- Limited high-quality research on optimal pharmacologic treatment 3, 5
The most recent evidence strongly supports a multifaceted approach with cannabis cessation as the cornerstone of treatment, supplemented by dopamine antagonists, benzodiazepines, and topical capsaicin for symptomatic relief during acute episodes 2, 1.